Offering patients post-ICU telehealth follow-up care that includes peer support could transform the recovery process and improve access to care.

Hospitalization for COVID-19 represents a coronary artery disease risk equivalent, contributing to an increased risk for major adverse cardiovascular events (MACE).

Non-Hispanic Black infants and Hispanic infants with atopic dermatitis faced significant barriers to diagnosis and health care utilization.

The use of high-dose vitamin B12 in patients with septic shock may not be associated with a mortality benefit.

Sufficient vitamin D levels may be associated with protection against ARIs, potentially through the induction of cathelicidin production.

Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.

False-negative patch tests in allergic contact dermatitis may occur due to immunosuppressive therapy use, UV exposure, and low allergen concentration.

Since winter 2023–2024, Omicron JN.1 lineage strains of SARS-CoV-2, including the JN.1 and the KP.2 strain, have been widely circulating in the United States. Recommendations for the 2024–2025 Novavax ...

Use of IV immunoglobulin was associated with a significantly reduced ICU length of stay in immunocompromised patients with respiratory viral infections.

The Food and Drug Administration has approved neoadjuvant/adjuvant Opdivo (nivolumab) for resectable non-small cell lung cancer.

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

Reduced antibiotic prescribing among patients with RTIs in primary care settings was not associated with increased risk for pneumonia hospitalization.